Law firm investigates Boston Scientific for alleged misleading growth claims in U.S. EP segment.

Bragar Eagel & Squire, P.C. is investigating Boston Scientific Corporation on behalf of long-term stockholders following a class action complaint filed in March 2026. The complaint alleges that Boston Scientific made false or misleading statements about the growth and competitive position of its U.S. Electrophysiology (EP) segment, which was reportedly facing unsustainable growth and new competition. The investigation focuses on whether the company's board breached fiduciary duties by not disclosing these issues, potentially misleading investors about the company's prospects. Long-term shareholders are encouraged to contact the law firm to discuss their legal options.